Invesco Ltd. Uni Qure N.V. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Uni Qure N.V. stock. As of the latest transaction made, Invesco Ltd. holds 110,917 shares of QURE stock, worth $632,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares

110,917

Previous 110,741 0.16%

Holding current value

$632,226

Previous $496,000 10.08%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.78 - $10.12 $665 - $1,781	176 Added 0.16%	110,917 $546,000
Q2 2024 Aug 13, 2024	BUY	$4.39 - $5.43 $9,407 - $11,636	2,143 Added 1.97%	110,741 $496,000
Q1 2024 May 14, 2024	BUY	$4.82 - $6.93 $350,891 - $504,497	72,799 Added 203.35%	108,598 $564,000
Q4 2023 Feb 12, 2024	SELL	$5.63 - $8.27 $32,254 - $47,378	-5,729 Reduced 13.8%	35,799 $242,000
Q3 2023 Nov 13, 2023	SELL	$6.71 - $11.83 $1.14 Million - $2 Million	-169,281 Reduced 80.3%	41,528 $278,000
Q2 2023 Aug 11, 2023	SELL	$11.12 - $22.2 $103,560 - $206,748	-9,313 Reduced 4.23%	210,809 $2.42 Million
Q1 2023 May 12, 2023	BUY	$18.7 - $23.07 $11,519 - $14,211	616 Added 0.28%	220,122 $4.43 Million
Q4 2022 Feb 13, 2023	SELL	$18.12 - $27.32 $5,073 - $7,649	-280 Reduced 0.13%	219,506 $4.98 Million
Q3 2022 Nov 14, 2022	SELL	$16.98 - $25.54 $71,214 - $107,114	-4,194 Reduced 1.87%	219,786 $4.12 Million
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $2.49 Million - $3.87 Million	-189,002 Reduced 45.77%	223,980 $4.18 Million
Q1 2022 May 16, 2022	SELL	$14.54 - $21.5 $28.5 Million - $42.2 Million	-1,961,253 Reduced 82.61%	412,982 $7.46 Million
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $1.58 Million - $2.8 Million	77,856 Added 3.39%	2,374,235 $49.2 Million
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $20.9 Million - $30.7 Million	-804,535 Reduced 25.95%	2,296,379 $73.5 Million
Q2 2021 Aug 17, 2021	SELL	$29.97 - $37.17 $6.6 Million - $8.19 Million	-220,346 Reduced 6.63%	3,100,914 $95.5 Million
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $3.21 Million - $4.61 Million	-109,633 Reduced 3.2%	3,321,260 $112 Million
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $46.1 Million - $66.1 Million	1,304,082 Added 61.32%	3,430,893 $124 Million
Q3 2020 Nov 16, 2020	BUY	$35.98 - $47.66 $2.45 Million - $3.25 Million	68,141 Added 3.31%	2,126,811 $78.3 Million
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $310,193 - $466,322	6,884 Added 0.34%	2,058,670 $92.8 Million
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $3.93 Million - $7.27 Million	-98,229 Reduced 4.57%	2,051,786 $97.4 Million
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $495,388 - $995,580	-13,342 Reduced 0.62%	2,150,015 $154 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $5.5 Million - $10.7 Million	139,837 Added 6.91%	2,163,357 $85.2 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $104 Million - $161 Million	1,963,390 Added 3265.24%	2,023,520 $158 Million
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $1.65 Million - $4.11 Million	60,130 New	60,130 $3.59 Million

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $266M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account